Charlene Rose Esters Tomasini

Mental Health Counselor


  290 Ioof Ave, Gilroy
     California, 95020-5204
  831-277-0163    Maps & Directions
Charlene Rose Esters Tomasini is a Gilroy, California based counselor who is specialized as Mental Health Counselor. Her current practice location is 290 Ioof Ave, Gilroy. Patients can book an appointment with her at 831-277-0163.
Charlene Rose Esters Tomasini is a licensed professional who helps individuals, couples, and families manage and overcome emotional, psychological, and behavioral challenges. She assess clients’ mental health conditions and develop personalized treatment plans to provide therapy for a range of mental health issues, including anxiety, depression, trauma, relationship issues, stress, grief, and life transitions.
Complete Profile:
Charlene Rose Esters Tomasini speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Charlene Rose Esters Tomasini
Specialization: Mental Health Counselor
Gender:Female
Accepts Medicare Assignment:No
Practice Address:290 Ioof Ave, Gilroy,
California, 95020-5204
Phone:831-277-0163
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1366103756
NPI Enumeration Date: 07 Jan, 2022
NPI Last Update On: 07 Jan, 2022

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 290 Ioof Ave,
Gilroy, California
Zip: 95020-5204
Patients can reach Charlene Rose Esters Tomasini at 290 Ioof Ave, Gilroy, California or can call to book an appointment on 831-277-0163.
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 June, 2025.

Comments/ Reviews: